Search

everythinglearnresearchcommunity

for

Search:↓

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Finasteride affects offspring's antioxidant enzymes in epididymis, possibly disrupting sperm maturation.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Phytoandrogens from plants may help treat low testosterone naturally.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

Women with PCOS have altered brain structure and reduced cognitive performance.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

PCOS diagnosis and management have improved with new guidelines for personalized care.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Plant-derived nanoparticles from Polygoni Multiflori Radix promote hair growth better than Minoxidil by affecting androgen pathways.

Seborrheic alopecia in adolescents is linked to hormones, stress, and lifestyle, and can be treated with medication, lifestyle changes, and therapy.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

PCOS may increase the risk of certain cancers.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Steroid cell tumors in the ovary are rare, can produce testosterone causing symptoms, and are mainly treated with surgery.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

Combining modern and Unani treatments may offer better care for hirsutism in PCOS.

A new gene variant causes glucocorticoid resistance in a mother and son.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

Hormones significantly affect skin health, with vitamin D playing a key role.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Obesity is linked to various skin problems and may increase the risk of skin cancer.